Determination of (4-(1,3-dioxo-1,3-dihydro-2H-isoindol- 2-yl)-N'-[(4-ethoxyphenyl) methylidene] benzohydrazide, a novel anti-inflammatory agent, in biological fluids by UPLC-MS/MS: Assay development, validation and in vitro metabolic stability study
about
Determination of (4-(1,3-dioxo-1,3-dihydro-2H-isoindol- 2-yl)-N'-[(4-ethoxyphenyl) methylidene] benzohydrazide, a novel anti-inflammatory agent, in biological fluids by UPLC-MS/MS: Assay development, validation and in vitro metabolic stability study
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Determination of (4-(1,3-dioxo ...... itro metabolic stability study
@ast
Determination of (4-(1,3-dioxo ...... itro metabolic stability study
@en
type
label
Determination of (4-(1,3-dioxo ...... itro metabolic stability study
@ast
Determination of (4-(1,3-dioxo ...... itro metabolic stability study
@en
prefLabel
Determination of (4-(1,3-dioxo ...... itro metabolic stability study
@ast
Determination of (4-(1,3-dioxo ...... itro metabolic stability study
@en
P2860
P356
P1476
Determination of (4-(1,3-dioxo ...... itro metabolic stability study
@en
P2093
Mashooq A Bhat
Mohammad Raish
P2860
P356
10.1002/BMC.3981
P577
2017-05-07T00:00:00Z